Cargando…

The development and validation of tau PET tracers: current status and future directions

PURPOSE: To provide an overview on positron emission tomography (PET) imaging of tau pathology in Alzheimer’s disease (AD) and other neurodegenerative disorders. RESULTS: Different classes of tau tracers such as flortaucipir, THK5317, and PBB3 have been developed and utilized in previous clinical st...

Descripción completa

Detalles Bibliográficos
Autores principales:	Okamura, Nobuyuki, Harada, Ryuichi, Ishiki, Aiko, Kikuchi, Akio, Nakamura, Tadaho, Kudo, Yukitsuka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2018
Materias:	Expert Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6096533/ https://www.ncbi.nlm.nih.gov/pubmed/30148121 http://dx.doi.org/10.1007/s40336-018-0290-y

Ejemplares similares

Characteristics of Tau and Its Ligands in PET Imaging
por: Harada, Ryuichi, et al.
Publicado: (2016)

Dynamic PET Measures of Tau Accumulation in Cognitively Normal Older Adults and Alzheimer’s Disease Patients Measured Using [18F] THK-5351
por: Lockhart, Samuel N., et al.
Publicado: (2016)

Longitudinal Assessment of Tau Pathology in Patients with Alzheimer’s Disease Using [(18)F]THK-5117 Positron Emission Tomography
por: Ishiki, Aiko, et al.
Publicado: (2015)

PT572. Advances in the Development of Tau PET Radiotracers and Their Clinical Applications
por: Yanai, Kazuhiko, et al.
Publicado: (2016)

Neuroimaging-pathological correlations of [(18)F]THK5351 PET in progressive supranuclear palsy
por: Ishiki, Aiko, et al.
Publicado: (2018)

Inappropriate Sinus Tachycardia: Current Challenges and Future Directions
por: Yasin, Omar Z., et al.
Publicado: (2018)

Imaging of Reactive Astrogliosis by Positron Emission Tomography
por: Harada, Ryuichi, et al.
Publicado: (2022)

Synthesis and pharmacokinetic characterisation of a fluorine-18 labelled brain shuttle peptide fusion dimeric affibody
por: Morito, Takahiro, et al.
Publicado: (2021)

The molecular pathology of schizophrenia: an overview of existing knowledge and new directions for future research
por: Nakamura, Takumi, et al.
Publicado: (2023)

Assessing THK523 selectivity for tau deposits in Alzheimer’s disease and non–Alzheimer’s disease tauopathies
por: Fodero-Tavoletti, Michelle T, et al.
Publicado: (2014)

Evaluation of (18)F labeled glial fibrillary acidic protein binding nanobody and its brain shuttle peptide fusion proteins using a neuroinflammation rat model
por: Morito, Takahiro, et al.
Publicado: (2023)

PET Imaging of Astrogliosis and Tau Facilitates Diagnosis of Parkinsonian Syndromes
por: Schönecker, Sonja, et al.
Publicado: (2019)

Current and Future Drug Targets in Weight Management
por: Witkamp, Renger F.
Publicado: (2010)

Current and future strategies against cutaneous parasites
por: Man, Ernest, et al.
Publicado: (2022)

Tau PET imaging: present and future directions
por: Saint-Aubert, Laure, et al.
Publicado: (2017)

(18)F-THK5351 Positron Emission Tomography Imaging in Neurodegenerative Tauopathies
por: Ezura, Michinori, et al.
Publicado: (2021)

Comparative binding properties of the tau PET tracers THK5117, THK5351, PBB3, and T807 in postmortem Alzheimer brains
por: Lemoine, Laetitia, et al.
Publicado: (2017)

[(18)F]THK-5351 PET imaging in early-stage semantic variant primary progressive aphasia: a report of two cases and a literature review
por: Kobayashi, Ryota, et al.
Publicado: (2018)

Dissecting the Binding Profile of PET Tracers to Corticobasal Degeneration Tau Fibrils
por: Zhou, Yang, et al.
Publicado: (2021)

Discriminatory ability of next-generation tau PET tracers for Alzheimer’s disease
por: Yap, Steven Y, et al.
Publicado: (2021)

Brain histamine H(1) receptor occupancy after oral administration of desloratadine and loratadine
por: Nakamura, Tadaho, et al.
Publicado: (2019)

Microneedle Mediated Transdermal Delivery of Protein, Peptide and Antibody Based Therapeutics: Current Status and Future Considerations
por: Kirkby, Melissa, et al.
Publicado: (2020)

Robotic-assisted radical prostatectomy with a single port platform: current and future perspectives of a referral center
por: Moschovas, Marcio Covas, et al.
Publicado: (2022)

The Sensitivity of Tau Tracers for the Discrimination of Alzheimer’s Disease Patients and Healthy Controls by PET
por: Mohammadi, Zohreh, et al.
Publicado: (2023)

Dual tracer tau PET imaging reveals different molecular targets for (11)C-THK5351 and (11)C-PBB3 in the Alzheimer brain
por: Chiotis, Konstantinos, et al.
Publicado: (2018)

Actionable imaging findings in the daily PET/CT scenario
por: Mattana, Francesco, et al.
Publicado: (2023)

Regional binding of tau and amyloid PET tracers in Down syndrome autopsy brain tissue
por: Lemoine, L., et al.
Publicado: (2020)

Tauvid™: The First FDA-Approved PET Tracer for Imaging Tau Pathology in Alzheimer’s Disease
por: Jie, Caitlin V. M. L., et al.
Publicado: (2021)

SPECT vs. PET in cardiac innervation imaging: clash of the titans
por: Werner, Rudolf A., et al.
Publicado: (2018)

Amino acid PET and MR perfusion imaging in brain tumours
por: Filss, Christian P., et al.
Publicado: (2017)

Breast cancer: initial workup and staging with FDG PET/CT
por: Groheux, David, et al.
Publicado: (2021)

PET Imaging in Preclinical Anti-Aβ Drug Development
por: Syvänen, Stina, et al.
Publicado: (2022)

The Future of Sleep Staging, Revisited
por: Stanley, Neil
Publicado: (2023)

Regional tau deposition and subregion atrophy of medial temporal structures in early Alzheimer's disease: A combined positron emission tomography/magnetic resonance imaging study
por: Sone, Daichi, et al.
Publicado: (2017)

Comparison of New Tau PET-Tracer Candidates With [(18)F]T808 and [(18)F]T807
por: Declercq, Lieven, et al.
Publicado: (2016)

Radiation dosimetry and pharmacokinetics of the tau PET tracer florzolotau (18F) in healthy Japanese subjects
por: Miyamoto, Masaomi, et al.
Publicado: (2023)

Association of deposition of tau and amyloid‐β proteins with structural connectivity changes in cognitively normal older adults and Alzheimer’s disease spectrum patients
por: Shigemoto, Yoko, et al.
Publicado: (2018)

Current ADC Linker Chemistry
por: Jain, Nareshkumar, et al.
Publicado: (2015)

The trigemino-cardiac reflex: a view to the future
por: Sandu, Nora, et al.
Publicado: (2010)

Future of translational research: Why go pragmatic?
por: Jazieh, Abdul Rahman
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_m7isrbhnunvcp9ibo3r8mr0a02